BLOOD COAGULATION & FIBRINOLYSIS, a distinguished journal in the field of hematology, is published by Lippincott Williams & Wilkins, a reputable name in academic publishing. Since its inception in 1990, this journal has been committed to advancing the understanding of blood coagulation and fibrinolysis, focusing on the molecular mechanisms, clinical implications, and therapeutic aspects of these critical processes. With an impact factor reflecting its significance within the academic community, currently ranking Q3 in both Hematology and Miscellaneous Medicine for 2023, this journal serves as a pivotal platform for researchers and professionals alike. By providing access to cutting-edge research and reviews, BLOOD COAGULATION & FIBRINOLYSIS endeavors to foster collaboration and innovation in the treatment of coagulation disorders. Interested readers can explore ongoing contributions to the field through subscriptions and institutional access options.

BLOOD REVIEWS is a highly regarded journal published by Churchill Livingstone, specializing in the fields of Hematology and Oncology. With an impressive Q1 ranking in both disciplines and placing in the top 10% of its peer categories according to Scopus metrics, it provides an essential platform for the dissemination of cutting-edge research and reviews pertaining to blood disorders and cancer treatment. Since its inception in 1987 and continuing through 2024, the journal has established itself as a cornerstone for healthcare professionals, researchers, and students who seek to advance their understanding of hematologic and oncologic topics. While not an open-access journal, BLOOD REVIEWS retains a reputation for delivering high-quality, peer-reviewed articles that foster dialogue and innovation within the scientific community. For those in the United States and beyond, the journal serves as a vital resource, housed at the Journal Production Department in Edinburgh, Scotland, ensuring accessibility and a global reach in its critical academic contributions.

THROMBOSIS RESEARCH is a leading peer-reviewed journal in the field of hematology, published by PERGAMON-ELSEVIER SCIENCE LTD. With an impressive impact factor and ranked within the top 10 of 137 in its category according to Scopus, this journal provides a critical platform for the dissemination of innovative research related to thrombosis and hemostasis. Established in 1972, THROMBOSIS RESEARCH has been at the forefront of scholarly communication, addressing key issues, findings, and advancements over more than five decades. Recognized for its high-quality content, the journal is categorized in the Q1 quartile for 2023, reflecting its influence and relevance within the scientific community. Researchers, medical professionals, and students engaged in the study of blood disorders will find valuable insights and the latest discoveries within its pages. Although currently not an open-access publication, THROMBOSIS RESEARCH remains accessible to a wide audience through institutional subscriptions, ensuring that vital research continues to inform and enhance clinical practices around the globe.

The British Journal of Pain is a leading publication in the field of Anesthesiology and Pain Medicine, expertly published by SAGE Publications Ltd from the United Kingdom. With an ISSN of 2049-4637 and an E-ISSN of 2049-4645, this journal has established itself as an essential resource for researchers and practitioners alike, achieving an impressive Q2 ranking in its category for 2023, as well as a Scopus rank of #53 out of 136 in Medicine – Anesthesiology and Pain Medicine. The journal spans a broad scope of topics related to pain management, therapeutic practices, and advancements in treatment methodologies, catering to both ongoing research and clinical applications. Researchers and professionals can access a wealth of knowledge that not only supports the academic community but also drives innovative practices in pain management. The British Journal of Pain recognizes the significance of evidence-based research and its application in clinical settings, making it a vital platform for advancing the understanding of pain and improving patient care.

Lymphatic Research and Biology, an esteemed journal published by MARY ANN LIEBERT, INC, plays a critical role in the exploration of lymphatic biology and its implications in cardiology and cardiovascular medicine. Established in 2003, this journal has dedicated itself to advancing our understanding of lymphatic function, disorders, and innovative therapeutic strategies, making it a significant resource for researchers and practitioners in the field. With an ISSN of 1539-6851 and an E-ISSN of 1557-8585, it provides a platform for cutting-edge research, reviews, and clinical studies aimed at bridging the gap between basic science and clinical applications. While currently not an open-access journal, it offers a wealth of knowledge pertinent to those involved in lymphatic health and cardiovascular research. With a 2023 Scopus ranking placing it in the second quartile (Q2) for Cardiology and Cardiovascular Medicine, this journal is poised to influence the next generation of scientific inquiry and practice.

MICROCIRCULATION, published by WILEY, is a leading journal dedicated to the exploration of microcirculatory processes in health and disease. With an ISSN of 1073-9688 and E-ISSN 1549-8719, this journal has been a vital resource in the fields of cardiology, molecular biology, and physiology since its convergence in the early 1980s. Given its impressive impact factor within its quartile rankings—Q2 in Cardiology and Cardiovascular Medicine, and Q3 in several other categories—MICROCIRCULATION is positioned as an influential platform for researchers and clinicians interested in the intricacies of microvascular function. While it is not an open-access journal, the research published here contributes significantly to the body of knowledge regarding microvascular health, cardiovascular adaptations, and related molecular mechanisms, appealing to a broad spectrum of academics and medical professionals committed to advancing their understanding in this critical area. Explore the breakthroughs and insights presented in MICROCIRCULATION and stay at the forefront of ongoing research and discussions.

The Journal of Vascular Surgery-Venous and Lymphatic Disorders, published by Elsevier, is a distinguished peer-reviewed journal dedicated to advancing the knowledge and practice of vascular surgery with a particular focus on venous and lymphatic conditions. With an ISSN of 2213-333X and a robust impact factor, this journal ranks Q2 in Cardiology and Cardiovascular Medicine and Q1 in Surgery, reflecting its high relevance and contribution to the field. Covering a wide spectrum of topics from innovative surgical techniques to the latest developments in venous and lymphatic disorders, the journal serves as a vital resource for researchers, clinicians, and students alike. It not only disseminates cutting-edge research but also promotes best practices and interdisciplinary collaboration within the cardiovascular domain. The journal is accessible to a global audience, ensuring that impactful findings reach practitioners and researchers everywhere, further elevating the standards of patient care and surgical excellence.

Current Reviews in Musculoskeletal Medicine, published by Springer, is a leading journal dedicated to the field of musculoskeletal health, contributing to the advancement of knowledge in orthopedics and sports medicine. With an impressive impact factor and consistently ranked in the Q1 category of its field (2023), this journal is recognized for its rigorous peer-reviewed articles that span from innovative research findings to comprehensive reviews. Published since 2008 and set to continue through 2024, the journal boasts a Scopus Rank of #23 out of 321, placing it in the top 92nd percentile within its category. Although access is not open, the journal's insights are invaluable for researchers, clinicians, and students seeking to stay updated on the latest advancements and evidence-based practices within musculoskeletal medicine. The esteemed contributions featured in this journal play a critical role in shaping the future of orthopedic practices and enhancing patient care outcomes.

Blood and Lymphatic Cancer-Targets and Therapy, published by DOVE MEDICAL PRESS LTD, is a vital open-access journal that has been disseminating crucial research and findings in the field of hematology and oncology since 2011. With its ISSN 1179-9889, this journal focuses on the latest therapeutic targets and innovative treatment strategies for blood and lymphatic cancers, contributing significantly to the advancement of knowledge and practice in this specialized area. Designed for researchers, healthcare professionals, and students alike, Blood and Lymphatic Cancer-Targets and Therapy aims to foster a deeper understanding of cancer biology and promote collaborative efforts leading to novel therapeutic interventions. The open-access model ensures that research findings are readily accessible to a global audience, underscoring the journal's commitment to enhancing patient care and fostering educational growth in the cancer domain.

Journal of Hematology & Oncology, published by BMC, is a leading open-access journal dedicated to the dynamic fields of hematology and oncology, with a continuous publication record since 2008. Based in the United Kingdom, this prestigious journal provides a platform for groundbreaking research, encompassing topics that span cancer research, hematological disorders, and molecular biology. With a remarkable Q1 ranking in multiple categories including Cancer Research, Hematology, Molecular Biology, and Oncology for 2023, it stands as a significant contributor to the scientific community. The journal's rigorous peer-review process ensures the dissemination of high-quality studies that drive advancements in these critical areas of medicine, boasting an impressive Scopus rank in the top echelons of its fields. As an open-access publication, it promotes widespread accessibility and sharing of knowledge, making it an indispensable resource for researchers, clinicians, and students striving to make advancements in understanding and treating hematological and oncological diseases.